Search Results - "Marks, Brynn E."

Monitoring of Pediatric Type 1 Diabetes by Marks, Brynn E, Wolfsdorf, Joseph I

“…Regular self-monitoring of blood glucose levels, and ketones when indicated, is an essential component of type 1 diabetes (T1D) management. Although…”
Get full text

Spontaneous and iatrogenic hypoglycemia in cystic fibrosis by Hicks, Rebecca, Marks, Brynn E., Oxman, Rachael, Moheet, Amir

“…•Spontaneous fasting and/or postprandial hypoglycemia is common in people with CF.•The clinical significance of OGTT related hypoglycemia in CF is not…”
Get full text

Differences in positive expectancy of hybrid closed loop (HCL) insulin delivery systems do not explain racial differences in HCL use by Grundman, Jody B., Perkins, Amanda, Monaghan, Maureen, Meighan, Seema, Streisand, Randi, Marks, Brynn E.

“…Hybrid closed loop (HCL) insulin delivery systems improve glycemia and quality of life among youth with type 1 diabetes (T1D), however there are inequities in…”
Get full text

Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems by Marks, Brynn E., Williams, Kristen M., Sherwood, Jordan S., Putman, Melissa S.

“…•Individuals with CFRD have unique diabetes physiology and comorbidities.•Perceptions of diabetes technology use in the CF community are positive.•Limited…”
Get full text

Case Report: Insulin hypersensitivity in youth with type 1 diabetes by Alkhatib, Einas H, Grundman, Jody B, Adamusiak, Anna M, Bellin, Melena D, Brooks, Joel P, Buckley, Kevin S, Janssen, Erin M, Kitcharoensakkul, Maleewan, McNerney, Kyle P, Pfeifer, Thea L, Polk, Brooke I, Marks, Brynn E

“…Immediate type I, type III, and delayed type IV hypersensitivity reactions to insulin are rare, but potentially serious complications of exogenous insulin…”
Get full text

Applying the use of shared medical appointments (SMAs) to improve continuous glucose monitor (CGM) use, glycemic control, and quality of life in marginalized youth with type 1 diabetes: Study protocol for a pilot prospective cohort study by Grundman, Jody B., Majidi, Shideh, Perkins, Amanda, Streisand, Randi, Monaghan, Maureen, Marks, Brynn E.

“…Continuous glucose monitors (CGMs) have been associated with improved glycemic control and diabetes-related quality of life in youth with type 1 diabetes…”
Get full text

Cystic fibrosis-related diabetes: The patient perspective by Mason, Kelly A., Marks, Brynn E., Wood, Colleen L., Le, Trang N.

“…Cystic fibrosis-related diabetes (CFRD) affects nearly 20% of adolescents and 40–50% of adults. However, the impact on patients and their families is poorly…”
Get full text

Advances in diabetes technology to improve the lives of people with cystic fibrosis by Scully, Kevin J., Marks, Brynn E., Putman, Melissa S.

“…People with cystic fibrosis (CF) are at risk for dysglycaemia caused by progressive beta cell dysfunction and destruction due to pancreatic exocrine disease…”
Get full text

Increase in the Diagnosis and Severity of Presentation of Pediatric Type 1 and Type 2 Diabetes during the COVID-19 Pandemic by Marks, Brynn E, Khilnani, Aneka, Meyers, Abby, Flokas, Myrto E, Gai, Jiaxiang, Monaghan, Maureen, Streisand, Randi, Estrada, Elizabeth

“…The impact of the COVID-19 pandemic on the incidence of pediatric type 1 (T1D) and type 2 diabetes (T2D) and severity of presentation at diagnosis is unclear…”
Get more information

1145-P: Hybrid Closed-Loop (HCL) Technology Improves Glycemic Control among Historically Marginalized Youth with Type 1 Diabetes (T1D) by MARKS, BRYNN E., GRUNDMAN, JODY, MEIGHAN, SEEMA, MONAGHAN, MAUREEN, STREISAND, RANDI, PERKINS, AMANDA G.

“…Background: Non-Hispanic Black (NHB) youth with T1D are more likely to have suboptimal glycemic control and less likely to use HCL systems or to be included in…”
Get full text

1132-P: It Takes 6!—Recruiting Marginalized Youth with T1D for Shared Medical Appointments (SMA) Pilot Study by GRUNDMAN, JODY, MAJIDI, SHIDEH, PERKINS, AMANDA G., STREISAND, RANDI, MONAGHAN, MAUREEN, MARKS, BRYNN E.

“…Introduction: Minority youth are underrepresented in diabetes technology trials. An ongoing pilot study is recruiting 20 publicly insured, insulin pump naive…”
Get full text

1137-P: Improvements in Diabetes-Related Quality of Life (DRQL) and Emotional Distress with Hybrid Closed-Loop (HCL) Technology in Marginalized Families with Suboptimally Controlled Type 1 Diabetes (T1D) by PERKINS, AMANDA G., GRUNDMAN, JODY, MEIGHAN, SEEMA, MONAGHAN, MAUREEN, STREISAND, RANDI, MARKS, BRYNN E.

“…Background: Prior HCL studies enrolling participants with well-controlled T1D and limited financial, racial-ethnic, and socioeconomic diversity have shown…”
Get full text

Endocrine Complications of Cystic Fibrosis by Kelly, Andrea, Marks, Brynn E., Stalvey, Michael S.

“…Endocrine comorbidities have become increasingly important medical considerations as improving cystic fibrosis (CF) care increases life expectancy. Although…”
Get full text

Hybrid Closed Loop Systems Improve Glycemic Control and Quality of Life in Historically Minoritized Youth with Diabetes by Marks, Brynn E, Grundman, Jody B, Meighan, Seema, Monaghan, Maureen, Streisand, Randi, Perkins, Amanda

“…We assessed changes in glycemic control and person-reported outcome measures (PROMs) with t:slim X2 insulin pump with Control-IQ technology use among…”
Get more information

Improving equity in diabetes technology use: Voices of youth and their parents by Perkins, Amanda, Hinds, Pamela S, Grundman, Jody B, Meighan, Seema, Monaghan, Maureen, Streisand, Randi, Marks, Brynn E

“…There are marked inequities in clinical outcomes and rates of diabetes technology use among youth with type 1 diabetes (T1D). The quantitative data from our…”
Get full text

Monitoring of paediatric type 1 diabetes by Marks, Brynn E., Wolfsdorf, Joseph I.

“…Purpose of review This article reviews recent developments in methods used to monitor paediatric type 1 diabetes (T1D), including an examination of the role of…”
Get full text

Gastric Bypass in an Adolescent with Obesity, Insulin Resistance, and Type 1 Diabetes by Stefater, Margaret A., Marks, Brynn E.

Get full text

Endpoints for clinical trials in type 1 diabetes drug development by Galderisi, Alfonso, Marks, Brynn E, DiMeglio, Linda A, de Beaufort, Carine

Get full text

The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes by Magge, Sheela N., Wolf, Risa M., Pyle, Laura, Brown, Elizabeth A., Benavides, Valeria C., Bianco, Monica E., Chao, Lily C., Cymbaluk, Anna, Balikcioglu, Pinar Gumus, Halpin, Kelsee, Hsia, Daniel S., Huerta-Saenz, Lina, Kim, Jane J., Kumar, Seema, Levitt Katz, Lorraine E., Marks, Brynn E., Neyman, Anna, O'Sullivan, Katie L., Pillai, Sabitha Sasidharan, Shah, Amy S., Shoemaker, Ashley H., Siddiqui, Juwairriyyah A.W., Srinivasan, Shylaja, Thomas, Inas H., Tryggestad, Jeanie B., Yousif, Maha F., Kelsey, Megan M.

“…To evaluate the frequency and severity of new cases of youth-onset type 2 diabetes in the US during the first year of the pandemic compared with the mean of…”
Get full text

Post-Transplantation Diabetes Mellitus in Pediatric Patients by Grundman, Jody B, Wolfsdorf, Joseph I, Marks, Brynn E

“…More than 80% of pediatric solid organ transplant (SOT) recipients now survive into young adulthood and many encounter transplant-related complications…”
Get more information